Hexarelin 5mg Muscle Growth

Reconstitution protocols documented in the research literature recommend adding 2 ml of sterile bacteriostatic water (0.9% benzyl alcohol) to a 5 mg vial, producing a solution at 2.5 mg per milliliter, i.e. 2500 mcg/ml. This concentration facilitates experimental doses within the 100-300 mcg range per injection with a standard 29G 1ml insulin syringe (40-120 IU on the graduation).

The pharmacokinetics of Hexarelin is characterized by a Tmax of 15-30 minutes after subcutaneous injection, a GH peak reaching its maximum at 30-45 minutes, and a plasma half-life of approximately 55 minutes. The total physiological duration of action is within the 90-120 minute window post-injection. Research protocols involving multiple-injection models recommend intervals of at least 3-4 hours between two administrations to allow partial resensitization of GHS-R1a.

The experimental doses commonly reported in animal models and short-duration clinical studies are between 1 and 2 mcg per kilogram body weight, approximately 75-150 mcg for a 75 kg subject. Some research protocols used higher doses (up to 4 mcg/kg), but Arvat 1997 studies showed saturation of the GH response beyond 2 mcg/kg, rendering higher doses pharmacologically useless and increasing the risk of rapid desensitization.

Chronic schemes reported in the literature typically alternate active periods of 4-6 weeks with 2-4 week pauses to allow recovery of GHS-R1a receptor sensitivity. The desensitization documented by Broglio 2002 after 16 days of twice-daily administration imposes this cyclicity stricter than for Ipamorelin or GHRP-6. Some protocols explore weekly alternation with Ipamorelin to preserve sensitivity without completely interrupting administration.

Association with a GHRH analog such as CJC-1295 DAC, Mod GRF 1-29 or Sermorelin produces a synergistic response superior to the sum of individual effects. Typical protocols use CJC-1295 DAC 1-2 mg/week plus Hexarelin 100-150 mcg 2-3x/day. The combination of Hexarelin plus CJC-1295 without DAC (Mod GRF 1-29) is also documented, with both molecules injected simultaneously 20-30 minutes before bedtime or in post-exercise period. Injection performed on an empty stomach (90 minutes without food, particularly without carbohydrates) optimizes the GH response by avoiding inhibition by insulin and post-prandial free fatty acids.

Before reconstitution, the lyophilized vial of Hexarelin 5mg must be stored between 2 and 8 degrees Celsius, in its original packaging, away from direct light and any heat source. Under these conditions, the lyophilizate stability is ensured for 24 to 36 months from the manufacturing date. Prolonged storage at ambient temperature (>25 degrees Celsius) must remain exceptional and not exceed 72 hours; beyond that, a risk of degradation and potency loss exists.

After reconstitution with sterile bacteriostatic water, the aqueous Hexarelin solution remains stable for approximately 30 days at 2-8 degrees Celsius. This duration approaches that observed for Ipamorelin and GHRP-6, slightly superior to the 14-21 days documented for Sermorelin due to the superior stability conferred by the D-methylation of Trp2. Prolonged conservation beyond 30 days remains conceivable for research applications but remains discouraged beyond 45-60 days due to progressive non-enzymatic degradation (Trp oxidation, peptide bond hydrolysis in aqueous environment).

Freezing at -20 degrees Celsius or less significantly extends the stability of the reconstituted solution, up to 90-120 days in optimal conditions. However, each freeze-thaw cycle partially degrades the molecule and must be avoided. Best practice is to aliquot the reconstituted solution into portions corresponding to 3-5 days of experimental use, then freeze the aliquots individually. The thawed multi-dose vial is then used for a maximum of 30 days in refrigeration at 2-8 degrees Celsius.

Protection against light is important but non-critical for Hexarelin, less photosensitive than peptides containing melanotropin or exposed tyrosine residues. Opaque packaging or storage in a closed refrigerator drawer suffices in most configurations. On the other hand, protection against intense mechanical agitation remains essential: never shake the vial violently during reconstitution. Gentle rotation between palms or slow tilting allows lyophilizate dissolution without denaturing the hexapeptide structure.

Any solution presenting a color change (normally colorless and clear), a precipitate, or particles in suspension must be immediately discarded. Visual inspection before each sampling is a mandatory practice in research context. Atlas Lab provides detailed recommendations for rigorous experimental traceability.